Evidence map›Paper›PMID 36034449›Full record

ArticleFrontiers in endocrinology2022

Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.

Qiong Bai, Min Shi, Xinli Sun, Qiu Lou, Hangya Peng, Zhuan Qu, Jiashuang Fan, Lifen Dai

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Epigenetic Mechanisms in Osteoporosis: Exploring the Power of mJournal of cellular and molecular medicine · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. mActa biochimica et biophysica Sinica · 2023
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Qiong BaiLaboratory of Genetic Breeding and Molecular Biology, Southwest Forestry University, Kunming, China.
Min ShiLaboratory of Genetic Breeding and Molecular Biology, Southwest Forestry University, Kunming, China.
Xinli SunNational Wetland Ecosystem Fixed Research Station of Yunnan Dianchi, Southwest Forestry University, Kunming, China.
Qiu LouDepartment of Internal Medicine, The Affiliated Hospital of Yunnan University, Kunming, China.
Hangya PengDepartment of Internal Medicine, Yunnan Fuwai Cardiovascular Hospital, Kunming, China.
Zhuan QuDepartment of Internal Medicine, Yunnan Fuwai Cardiovascular Hospital, Kunming, China.
Jiashuang FanDepartment of Internal Medicine, Yunnan Fuwai Cardiovascular Hospital, Kunming, China.
Lifen DaiDepartment of Internal Medicine, Yunnan Fuwai Cardiovascular Hospital, Kunming, China.
Fuwai Yunnan Cardiovascular Hospital · CNSouthwest Forestry University · CNKunming Medical University · CNYunnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: N6-methyladenosine (m6A) modification is a critical epigenetic modification in eukaryotes and involves several biological processes and occurrences of diseases. However, the roles and regulatory mechanisms of m6A regulators in osteoporosis (OP) remain unclear. Thus, the purpose of this study is to explore the roles and mechanisms of m6A regulators in OP. Methods: The mRNA and microRNA (miRNA) expression profiles were respectively obtained from GSE56815, GSE7158, and GSE93883 datasets in Gene Expression Omnibus (GEO). The differential expression of 21 m6A regulators between high-bone mineral density (BMD) and low-BMD women was identified. Then, a consensus clustering of low-BMD women was performed based on differentially expressed (DE)-m6A regulators. The m6A-related differentially expressed genes (DEGs), the differentially expressed miRNAs (DE-miRNAs), and biological functions were investigated. Moreover, a weighted gene co-expression network analysis (WGCNA) was constructed to identify the OP-related hub modules, hub genes, and the functional pathways. Then, an m6A regulator-target-pathway network and the competing endogenous RNA (ceRNA) network in key modules were constructed. A least absolute shrinkage and selection operation (LASSO) Cox regression model and a Support Vector Machine-Recursive Feature Elimination (SVM-RFE) model were constructed to identify the candidate genes for OP prediction. The receiver operator characteristic (ROC) curves were used to validate the performances of predictive models and candidate genes. Results: A total of 10,520 DEGs, 13 DE-m6A regulators, and 506 DE-miRNAs between high-BMD and low-BMD women were identified. Two m6A-related subclusters with 13 DE-m6A regulators were classified for OP. There were 5,260 m6A-related DEGs identified between two m6A-related subclusters, the PI3K-Akt, MAPK, and immune-related pathways, and bone metabolism was mainly enriched in cluster 2. Cell cycle-related pathways, RNA methylation, and cell death-related pathways were significantly involved in cluster 1. Five modules were identified as key modules based on WGCNA, and an m6A regulator-target gene-pathway network and the ceRNA network were constructed in module brown. Moreover, three m6A regulators (FTO, YTHDF2, and CBLL1) were selected as the candidate genes for OP. Conclusion: M6A regulators play an important role in the occurrences and diagnosis of OP.

Indexed as

MicroRNAsOsteoporosisAlpha-Ketoglutarate-Dependent Dioxygenase FTOBiomarkersFemaleGene Regulatory NetworksHumansPhosphatidylinositol 3-KinasesUbiquitin-Protein LigasesAlpha-Ketoglutarate-Dependent Dioxygenase FTOBiomarkersCBLL1 protein, humanFTO protein, humanMicroRNAsPhosphatidylinositol 3-KinasesUbiquitin-Protein Ligasesdiagnostic markersmolecular patternsN6-methyladenosineOsteoporosisWGCNA

Identifiers

PMID36034449
PMCPMC9399504
OpenAlexW4292661177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.